Given the constant development in recent years, MD data might become an important part of new drug submissions and clinical treatment algorithms, and might positively influence patient benefit in the future. (C) 2011 Elsevier Ltd. All rights reserved.”
“The aim of the study was to assess the feasibility,
AS1842856 efficacy and safety of the use of a conical self-expandable stent for the treatment of post-pneumonectomy bronchopleural fistula (PPBPF). Between April 2008 and November 2010, six patients underwent treatment for the PPBPF by the introduction of a tracheobronchial conical fully covered self-expandable nitinol stent with the aim of excluding the bronchial dehiscence from the airflow. We secured the prosthesis to the tracheal mucosa with titanium helical fasteners tacks. Five patients presented with a bronchial fistula larger than 5 mm following right (4) or left (1) pneumonectomy. One patient had an anastomotic dehiscence after right tracheal sleeve pneumonectomy. A chest tube showed the absence of empyema in all cases. Immediate resolution of the bronchial air leak was obtained in all the patients. Permanent closure of the bronchial dehiscence without
recurrence was achieved in all the patients at a mean follow-up time of 13 months (range 3-32). The bronchial stent was successfully removed in all patients without sequelae 71-123 days after its implantation. The use of the conical self-expandable Silmet (R) stent has proved to be an effective, safe and fast method to treat even large PPBPFs.”
“OBJECTIVE: To estimate whether women who deliver small babies due to preterm MK-2206 birth or growth restriction have excess risk for cardiovascular disease and diabetes later in life.
METHODS: Eight years after pregnancy, we estimated the prevalence of metabolic syndrome and its components in a cohort study of women with prior
preterm (preterm birth before 37 weeks, n = 181) or small for gestational age ([SGA], less than the tenth percentile, n = 192) births, compared with women with term births (37 or more weeks, n = 306). Women delivered at Magee-Womens Hospital in Pittsburgh, Pennsylvania, and those with preeclampsia or prepregnancy selleck chemical diabetes or hypertension were excluded. Women underwent a structured interview and fasting blood sampling.
RESULTS: Women were, on average, 8 years postpartum and 39 years old at evaluation. Women with a prior preterm birth had higher blood pressure, triglycerides, and LDL-cholesterol compared with those in a term control group. Women with prior SGA births were leaner and more likely to smoke compared with those with term births. Women with prior preterm birth had elevated risk of metabolic syndrome, adjusted for demographic, smoking and body size factors (23% preterm compared with 17% control group; odds ratio [OR] 1.76 [1.06, 2.80]). In women with a prior preterm birth, low HDL (11% preterm compared with 5% control group; OR 2.6 [1.2, 5.